Ovid Therapeutics (OVID) Selling, General & Administrative (2016 - 2026)
Powered by 
Analysis
Ovid Therapeutics (OVID) Selling, General & Administrative (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 3.41 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -2.87 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 110.21 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 593.21 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 351.74 Mn |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | 6.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47 Mn |
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | 6.42 Mn |
| Sep 30, 2025 | 6.79 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Dec 31, 2024 | 4.88 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 7.17 Mn |
| Dec 31, 2023 | 7.69 Mn |
| Sep 30, 2023 | 6.81 Mn |
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | 8.34 Mn |
| Dec 31, 2022 | 6.66 Mn |
| Sep 30, 2022 | 7.63 Mn |
| Jun 30, 2022 | 8.26 Mn |
| Mar 31, 2022 | 9.88 Mn |
| Dec 31, 2021 | 8.26 Mn |
| Sep 30, 2021 | 6.76 Mn |